APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Covid-19 Treatment

Patients today have more treatment options in the battle against coronavirus disease.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In this report, we study all treatment method for Covid-19.

Selected research

Industry Growth & Trends

Global Covid-19 Treatment Industry Growth and Trends Forecast to 2032

Report ID 173893890127 December 2025114 pages

Choose your research edition.

Industry ResearchCovid-19 Treatment Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Covid-19 Treatment Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Covid-19 Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Covid-19 Treatment Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Covid-19 Treatment Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

Read the full market overview

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In this report, we study all treatment method for Covid-19.

According to APO Research, the global Covid-19 Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

This report provides a structured, data-driven view of the global Covid-19 Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Covid-19 Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Covid-19 Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Covid-19 Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Covid-19 Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Covid-19 Treatment Market by Company

Cadila Healthcare

Johnson & Johnson

ImmunoPrecise

Novartis

AstraZeneca

Cipla

AbbVie

Bayer

Regeneron Pharmaceuticals

Ascletis Pharma

GlaxoSmithKline

Gilead Sciences

Pharmstandard

Fujifilm Holdings

Zhejiang Hisun Pharmaceutical Co. Ltd

Roche

Sanofi

Pfizer

Eli Lilly

Covid-19 Treatment Segment by Type

Life Support

Antiviral Medicine

Antibody Treatments

Others

Covid-19 Treatment Segment by End User

Children

Adult

Covid-19 Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Covid-19 Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Covid-19 Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Covid-19 Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Covid-19 Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Covid-19 Treatment Market Share by Region (2021-2026) Table 4. Global Covid-19 Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Covid-19 Treatment Market Share by Region (2027-2032) Table 6. Global Covid-19 Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Covid-19 Treatment Market Size Share by Type (2021-2026) Table 9. Global Covid-19 Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Covid-19 Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Covid-19 Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Covid-19 Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Covid-19 Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Covid-19 Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Covid-19 Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Covid-19 Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Covid-19 Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Covid-19 Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Covid-19 Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Covid-19 Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Covid-19 Treatment Market Size by End User (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Covid-19 Treatment Market Size by End User (2021-2026) & (US$ Million) Table 23. Global Covid-19 Treatment Market Size Share by End User (2021-2026) Table 24. Global Covid-19 Treatment Market Size Forecasted by End User (2027-2032) & (US$ Million) Table 25. Global Covid-19 Treatment Market Size Share Forecasted by End User (2027-2032) Table 26. North America Covid-19 Treatment Market Size Breakdown by End User (2021-2026) & (US$ Million) Table 27. North America Covid-19 Treatment Market Size Breakdown by End User (2027-2032) & (US$ Million) Table 28. Europe Covid-19 Treatment Market Size Breakdown by End User (2021-2026) & (US$ Million) Table 29. Europe Covid-19 Treatment Market Size Breakdown by End User (2027-2032) & (US$ Million) Table 30. Asia-Pacific Covid-19 Treatment Market Size Breakdown by End User (2021-2026) & (US$ Million) Table 31. Asia-Pacific Covid-19 Treatment Market Size Breakdown by End User (2027-2032) & (US$ Million) Table 32. Latin America Covid-19 Treatment Market Size Breakdown by End User (2021-2026) & (US$ Million) Table 33. Latin America Covid-19 Treatment Market Size Breakdown by End User (2027-2032) & (US$ Million) Table 34. Middle East and Africa Covid-19 Treatment Market Size Breakdown by End User (2021-2026) & (US$ Million) Table 35. Middle East and Africa Covid-19 Treatment Market Size Breakdown by End User (2027-2032) & (US$ Million) Table 36. Covid-19 Treatment Industry Trends Table 37. Covid-19 Treatment Industry Drivers Table 38. Covid-19 Treatment Industry Opportunities and Challenges Table 39. Covid-19 Treatment Industry Restraints Table 40. Global Covid-19 Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Covid-19 Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Covid-19 Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Covid-19 Treatment Key Company Headquarters & Area Served Table 44. Global Covid-19 Treatment Company, Product Type & Application Table 45. Global Covid-19 Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Cadila Healthcare Company Information Table 49. Cadila Healthcare Business Overview Table 50. Cadila Healthcare Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Cadila Healthcare Covid-19 Treatment Product Portfolio Table 52. Cadila Healthcare Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Covid-19 Treatment Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. ImmunoPrecise Company Information Table 59. ImmunoPrecise Business Overview Table 60. ImmunoPrecise Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. ImmunoPrecise Covid-19 Treatment Product Portfolio Table 62. ImmunoPrecise Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Covid-19 Treatment Product Portfolio Table 67. Novartis Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca Covid-19 Treatment Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cipla Covid-19 Treatment Product Portfolio Table 77. Cipla Recent Development Table 78. AbbVie Company Information Table 79. AbbVie Business Overview Table 80. AbbVie Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AbbVie Covid-19 Treatment Product Portfolio Table 82. AbbVie Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bayer Covid-19 Treatment Product Portfolio Table 87. Bayer Recent Development Table 88. Regeneron Pharmaceuticals Company Information Table 89. Regeneron Pharmaceuticals Business Overview Table 90. Regeneron Pharmaceuticals Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Regeneron Pharmaceuticals Covid-19 Treatment Product Portfolio Table 92. Regeneron Pharmaceuticals Recent Development Table 93. Ascletis Pharma Company Information Table 94. Ascletis Pharma Business Overview Table 95. Ascletis Pharma Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Ascletis Pharma Covid-19 Treatment Product Portfolio Table 97. Ascletis Pharma Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Covid-19 Treatment Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Gilead Sciences Company Information Table 104. Gilead Sciences Business Overview Table 105. Gilead Sciences Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Gilead Sciences Covid-19 Treatment Product Portfolio Table 107. Gilead Sciences Recent Development Table 108. Pharmstandard Company Information Table 109. Pharmstandard Business Overview Table 110. Pharmstandard Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Pharmstandard Covid-19 Treatment Product Portfolio Table 112. Pharmstandard Recent Development Table 113. Fujifilm Holdings Company Information Table 114. Fujifilm Holdings Business Overview Table 115. Fujifilm Holdings Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Fujifilm Holdings Covid-19 Treatment Product Portfolio Table 117. Fujifilm Holdings Recent Development Table 118. Zhejiang Hisun Pharmaceutical Co. Ltd Company Information Table 119. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview Table 120. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product Portfolio Table 122. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development Table 123. Roche Company Information Table 124. Roche Business Overview Table 125. Roche Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Roche Covid-19 Treatment Product Portfolio Table 127. Roche Recent Development Table 128. Sanofi Company Information Table 129. Sanofi Business Overview Table 130. Sanofi Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Sanofi Covid-19 Treatment Product Portfolio Table 132. Sanofi Recent Development Table 133. Pfizer Company Information Table 134. Pfizer Business Overview Table 135. Pfizer Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Pfizer Covid-19 Treatment Product Portfolio Table 137. Pfizer Recent Development Table 138. Eli Lilly Company Information Table 139. Eli Lilly Business Overview Table 140. Eli Lilly Covid-19 Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Eli Lilly Covid-19 Treatment Product Portfolio Table 142. Eli Lilly Recent Development Table 143. North America Covid-19 Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Covid-19 Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Covid-19 Treatment Market Share by Country (2021-2026) Table 146. North America Covid-19 Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Covid-19 Treatment Market Share Forecast by Country (2027-2032) Table 148. Europe Covid-19 Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Covid-19 Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Covid-19 Treatment Market Share by Country (2021-2026) Table 151. Europe Covid-19 Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Covid-19 Treatment Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Covid-19 Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Covid-19 Treatment Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Covid-19 Treatment Market Share by Country (2021-2026) Table 156. Asia-Pacific Covid-19 Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Covid-19 Treatment Market Share Forecast by Country (2027-2032) Table 158. Latin America Covid-19 Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Covid-19 Treatment Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Covid-19 Treatment Market Share by Country (2021-2026) Table 161. Latin America Covid-19 Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Covid-19 Treatment Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Covid-19 Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Covid-19 Treatment Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Covid-19 Treatment Market Share by Country (2021-2026) Table 166. Middle East & Africa Covid-19 Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Covid-19 Treatment Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Covid-19 Treatment Product Image Figure 3. Global Covid-19 Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Covid-19 Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Covid-19 Treatment Market Share by Region (2021-2032) Figure 7. North America Covid-19 Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Covid-19 Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Covid-19 Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Covid-19 Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Covid-19 Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Life Support Image Figure 13. Global Life Support Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antiviral Medicine Image Figure 15. Global Antiviral Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Antibody Treatments Image Figure 17. Global Antibody Treatments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Covid-19 Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Covid-19 Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Covid-19 Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Covid-19 Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Covid-19 Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Covid-19 Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Covid-19 Treatment Market Size Share by Type (2021-2032) Figure 27. Children Image Figure 28. Global Children Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Adult Image Figure 30. Global Adult Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Covid-19 Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Covid-19 Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Covid-19 Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Covid-19 Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Covid-19 Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Covid-19 Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Covid-19 Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Covid-19 Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Covid-19 Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Covid-19 Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Covid-19 Treatment Market Share by Country (2021-2032) Figure 43. Europe Covid-19 Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Covid-19 Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Covid-19 Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Covid-19 Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Covid-19 Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Covid-19 Treatment Market Share by Country (2021-2032) Figure 49. Latin America Covid-19 Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Covid-19 Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Covid-19 Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Covid-19 Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Covid-19 Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Covid-19 Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Life Support
  • Antiviral Medicine
  • Antibody Treatments
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Cadila Healthcare
  • Johnson & Johnson
  • ImmunoPrecise
  • Novartis
  • AstraZeneca
  • Cipla
  • AbbVie
  • Bayer
  • Regeneron Pharmaceuticals
  • Ascletis Pharma
  • GlaxoSmithKline
  • Gilead Sciences
  • Pharmstandard
  • Fujifilm Holdings
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Roche
  • Sanofi
  • Pfizer
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Covid-19 Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Covid-19 Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Covid-19 Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Covid-19 Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Covid-19 Treatment Market Size (2021-2032)
  8. 1.5.1 North America Covid-19 Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Covid-19 Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Covid-19 Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Covid-19 Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Covid-19 Treatment Market Size Growth Rate (2021-2032)
2 Covid-19 Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Life Support
  3. 2.1.2 Antiviral Medicine
  4. 2.1.3 Antibody Treatments
  5. 2.1.4 Others
  6. 2.2 Global Covid-19 Treatment Market Size by Type
  7. 2.2.1 Global Covid-19 Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Covid-19 Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Covid-19 Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Covid-19 Treatment Market Size by Regions
  11. 2.3.1 North America Covid-19 Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Covid-19 Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Covid-19 Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Covid-19 Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Covid-19 Treatment Market Size Breakdown by Type (2021-2026)
3 Covid-19 Treatment Market by End User
  1. 3.1 Type Introduction
  2. 3.1.1 Children
  3. 3.1.2 Adult
  4. 3.2 Global Covid-19 Treatment Market Size by End User
  5. 3.2.1 Global Covid-19 Treatment Market Size Overview by End User (2021-2032)
  6. 3.2.2 Global Covid-19 Treatment Historic Market Size Review by End User (2021-2026)
  7. 3.2.3 Global Covid-19 Treatment Market Size Forecasted by End User (2027-2032)
  8. 3.3 Global Covid-19 Treatment Market Size by Regions
  9. 3.3.1 North America Covid-19 Treatment Market Size Breakdown by End User (2021-2026)
  10. 3.3.2 Europe Covid-19 Treatment Market Size Breakdown by End User (2021-2026)
  11. 3.3.3 Asia-Pacific Covid-19 Treatment Market Size Breakdown by End User (2021-2026)
  12. 3.3.4 South America Covid-19 Treatment Market Size Breakdown by End User (2021-2026)
  13. 3.3.5 Middle East and Africa Covid-19 Treatment Market Size Breakdown by End User (2021-2026)
4 Global Market Dynamics
  1. 4.1 Covid-19 Treatment Industry Trends
  2. 4.2 Covid-19 Treatment Industry Drivers
  3. 4.3 Covid-19 Treatment Industry Opportunities and Challenges
  4. 4.4 Covid-19 Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Covid-19 Treatment Revenue (2021-2026)
  2. 5.2 Global Covid-19 Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Covid-19 Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Covid-19 Treatment Company, Product Type & Application
  5. 5.5 Global Covid-19 Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Covid-19 Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Covid-19 Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Covid-19 Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Cadila Healthcare
  2. 6.1.1 Cadila Healthcare Company Information
  3. 6.1.2 Cadila Healthcare Business Overview
  4. 6.1.3 Cadila Healthcare Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Cadila Healthcare Covid-19 Treatment Product Portfolio
  6. 6.1.5 Cadila Healthcare Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Covid-19 Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 ImmunoPrecise
  14. 6.3.1 ImmunoPrecise Company Information
  15. 6.3.2 ImmunoPrecise Business Overview
  16. 6.3.3 ImmunoPrecise Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 ImmunoPrecise Covid-19 Treatment Product Portfolio
  18. 6.3.5 ImmunoPrecise Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Covid-19 Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Covid-19 Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Covid-19 Treatment Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Covid-19 Treatment Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Covid-19 Treatment Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Regeneron Pharmaceuticals
  50. 6.9.1 Regeneron Pharmaceuticals Company Information
  51. 6.9.2 Regeneron Pharmaceuticals Business Overview
  52. 6.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Product Portfolio
  54. 6.9.5 Regeneron Pharmaceuticals Recent Developments
  55. 6.10 Ascletis Pharma
  56. 6.10.1 Ascletis Pharma Company Information
  57. 6.10.2 Ascletis Pharma Business Overview
  58. 6.10.3 Ascletis Pharma Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Ascletis Pharma Covid-19 Treatment Product Portfolio
  60. 6.10.5 Ascletis Pharma Recent Developments
  61. 6.11 GlaxoSmithKline
  62. 6.11.1 GlaxoSmithKline Company Information
  63. 6.11.2 GlaxoSmithKline Business Overview
  64. 6.11.3 GlaxoSmithKline Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline Covid-19 Treatment Product Portfolio
  66. 6.11.5 GlaxoSmithKline Recent Developments
  67. 6.12 Gilead Sciences
  68. 6.12.1 Gilead Sciences Company Information
  69. 6.12.2 Gilead Sciences Business Overview
  70. 6.12.3 Gilead Sciences Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Gilead Sciences Covid-19 Treatment Product Portfolio
  72. 6.12.5 Gilead Sciences Recent Developments
  73. 6.13 Pharmstandard
  74. 6.13.1 Pharmstandard Company Information
  75. 6.13.2 Pharmstandard Business Overview
  76. 6.13.3 Pharmstandard Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Pharmstandard Covid-19 Treatment Product Portfolio
  78. 6.13.5 Pharmstandard Recent Developments
  79. 6.14 Fujifilm Holdings
  80. 6.14.1 Fujifilm Holdings Company Information
  81. 6.14.2 Fujifilm Holdings Business Overview
  82. 6.14.3 Fujifilm Holdings Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Fujifilm Holdings Covid-19 Treatment Product Portfolio
  84. 6.14.5 Fujifilm Holdings Recent Developments
  85. 6.15 Zhejiang Hisun Pharmaceutical Co. Ltd
  86. 6.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Information
  87. 6.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
  88. 6.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product Portfolio
  90. 6.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
  91. 6.16 Roche
  92. 6.16.1 Roche Company Information
  93. 6.16.2 Roche Business Overview
  94. 6.16.3 Roche Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Roche Covid-19 Treatment Product Portfolio
  96. 6.16.5 Roche Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Sanofi Covid-19 Treatment Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Pfizer
  104. 6.18.1 Pfizer Company Information
  105. 6.18.2 Pfizer Business Overview
  106. 6.18.3 Pfizer Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Pfizer Covid-19 Treatment Product Portfolio
  108. 6.18.5 Pfizer Recent Developments
  109. 6.19 Eli Lilly
  110. 6.19.1 Eli Lilly Company Information
  111. 6.19.2 Eli Lilly Business Overview
  112. 6.19.3 Eli Lilly Covid-19 Treatment Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Eli Lilly Covid-19 Treatment Product Portfolio
  114. 6.19.5 Eli Lilly Recent Developments
7 North America
  1. 7.1 North America Covid-19 Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Covid-19 Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Covid-19 Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Covid-19 Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Covid-19 Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Covid-19 Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Covid-19 Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Covid-19 Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Covid-19 Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Covid-19 Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Covid-19 Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Covid-19 Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Covid-19 Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Covid-19 Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Covid-19 Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst